Margery Fischbein

Margery Fischbein is the current Director at Cytodel. Prior to this, they were the Managing Director and Head of East Coast Biotechnology at JMP Securities from March 2011 to August 2014. Margery then moved to FBR Capital Markets & Co. and served as the Senior Managing Director & Group Head Healthcare Investment Banking from September 2014 to June 2017. Margery has also held positions at Beal Advisors as Managing Director from January 2009 to March 2011, and Paramount BioSciences as EVP, M&A from January 2008 to December 2009.

Margery Fischbein has an MBA in Finance from Harvard Business School and a BA in Economics from Harvard University.